about
Pharmacokinetic/pharmacodynamic modeling in inflammationDevelopmental pharmacokinetics in pediatric populationsStrategic biomarkers for drug development in treating rare diseases and diseases in neonates and infantsCharacterizing the impact of development on the dose-exposure-response relationship: challenge or opportunity?Pharmacogenomics--how close/far are we to practising individualized medicine for children?How children's responses to drugs differ from adults.Modelling approaches to dose estimation in childrenEffect of Kidney Function on Drug Kinetics and Dosing in Neonates, Infants, and ChildrenDifferences in absorption, distribution, metabolism and excretion of xenobiotics between the paediatric and adult populations.Pharmacogenetics and paediatric drug development: issues and consequences to labelling and dosing recommendations.Adverse drug reactions in newborns, infants and toddlers: pediatric pharmacovigilance between present and future.Do children have the same vulnerability to metabolic drug–drug interactions as adults? A critical analysis of the literature.Applications of physiologically based pharmacokinetic modeling for the optimization of anti-infective therapies.Resurgence in the use of physiologically based pharmacokinetic models in pediatric clinical pharmacology: parallel shift in incorporating the knowledge of biological elements and increased applicability to drug development and clinical practice.Cyclosporine/ketoconazole reduces treatment costs for nephrotic syndrome.Autoantibodies against cytochrome P450s in sera of children treated with immunosuppressive drugs.Lack of compliance of European Public Assessment Reports to guidelines for paediatric drug development before the introduction of paediatric investigation plans.Inosine monophosphate dehydrogenase activity in paediatrics: age-related regulation and response to mycophenolic acid.A drug transporter for all ages? ABCB1 and the developmental pharmacogenetics of cyclosporine.
P2860
Q26830621-4EA5E5A8-92A2-4DCC-BBAF-F8B7BE1ED254Q27002933-FAAF3DB3-0DFC-4E74-89AA-8732F556F82CQ27024346-5E3C1FA1-6C2B-43A8-8FA1-88F84BA9C5A1Q35124112-5E118435-BC79-4C7C-9A1C-D8568283BD5AQ35135951-DF30C719-CC31-4813-A009-A6980920C5E3Q35827035-D0C2890E-9C36-4FC4-B86F-FF34BD8EBB64Q35827045-55F515BE-9051-4136-9B1F-FB114A476566Q36322918-A9CCB139-D553-45D9-B2A7-37CA0CEDB684Q36544972-DB37FBE8-5A7A-4860-9D3A-A52EA909936AQ36909252-5B0E6FF4-05F9-41CD-B4C3-3C074AC0687CQ37872784-C0679EAF-D694-469D-B4B4-1BD8364D1ED4Q38110809-3D33B3C0-E35F-42C8-85CA-DB6E7A857904Q38420688-DA7357B3-1246-467E-BEFD-4C03F4E4C8B6Q39870288-ECFB13B4-00C0-4834-8D16-D28E85E95B5FQ41968631-45126C93-5B24-4929-8E7C-001158B85D25Q43904331-B3B46FDE-5866-40A6-8929-DF617ADA7755Q45894333-B2426476-F2D5-401C-91E5-94E64B8606C2Q50972464-68788D4E-6C2B-4880-9E1C-E762EB74B9F4Q51955888-E001BDDA-12B4-4744-A8E6-9C7D6A9B17F2
P2860
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年学术文章
@wuu
1999年学术文章
@zh
1999年学术文章
@zh-cn
1999年学术文章
@zh-hans
1999年学术文章
@zh-my
1999年学术文章
@zh-sg
1999年學術文章
@yue
1999年學術文章
@zh-hant
name
Developmental pharmacodynamics of cyclosporine.
@en
Developmental pharmacodynamics of cyclosporine.
@nl
type
label
Developmental pharmacodynamics of cyclosporine.
@en
Developmental pharmacodynamics of cyclosporine.
@nl
prefLabel
Developmental pharmacodynamics of cyclosporine.
@en
Developmental pharmacodynamics of cyclosporine.
@nl
P1476
Developmental pharmacodynamics of cyclosporine.
@en
P2093
Marshall JD
P356
10.1016/S0009-9236(99)70055-X
P407
P577
1999-07-01T00:00:00Z